All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.

  TRANSLATE

The mpn Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mpn Hub cannot guarantee the accuracy of translated content. The mpn and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The MPN Hub is an independent medical education platform, sponsored by AOP Health and GSK, and supported through an educational grant from Bristol Myers Squibb and Incyte. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Factors influencing delays in MPN presentation and diagnosis: A cross-sectional study

By Jen Wyatt Green

Share:

May 21, 2025

Learning objective: After reading this article, learners will be able to cite a new clinical development in myeloproliferative neoplasms.


 

Recognition of cancer at an early stage is critical for improving patient outcomes. Delayed diagnosis is common in patients with MPN due to their rarity and the broad symptom profile of hematological malignancies, increasing the risk of prediagnostic thromboembolic events and other complications. A clear understanding of the barriers to presentation and diagnosis is required. 

 

To determine the barriers to early diagnosis of MPN, Tarburn et al. conducted an online, cross-sectional study of 620 patients with MPN (ET, n = 324; PV, n = 235; primary MF, n = 43; other subtypes, n = 18) in the UK and the Republic of Ireland. The study examined symptoms and factors that influenced delays in patient presentation, using adjusted odds ratios (aORs) to investigate the relationship between these factors and delays in GP referral. Findings were published in the British Journal of General Practice.1 

 

Key learnings

Patient factors significantly associated with delayed presentation included attributing symptoms to ageing (aOR, 1.92; 95% CI, 1.19–3.11) and not wanting to burden their GP (aOR, 2.04; 95% CI, 1.24–3.39).  

Most patients (80.2%) reported symptomatic presentation. Symptoms most commonly associated with delayed patient presentation included pruritus (aOR, 1.89; 95% CI, 1.19–3.01), headaches (aOR, 1.86; 95% CI, 1.13–2.82), and concentration difficulties (aOR, 1.75; 95% CI, 1.12–2.76). 

Patients reporting >3 signs of hematological cancer were more likely to experience a GP delay (from initial presentation to referral) vs those reporting ≤1 sign (aOR, 3.26; 95% CI, 1.75–6.29). Lack of relational continuity of GP care was significantly associated with GP delay (aOR, 3.41; 95% CI, 1.65–7.28). 

Challenging preconceptions about ageing, encouraging timely GP communication, and improving relational continuity of GP care could reduce diagnostic delays and potentially fatal disease complications. Improved awareness of the consequences of late diagnosis in the primary care setting is vital to improving patient outcomes. 

Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; ET, essential thrombocytopenia; GP, general practitioner; MF, myelofibrosis; MPN, myeloproliferative neoplasms; PV, polycythemia vera. 

References

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content